Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer
Yihao Mao,1,* Qingyang Feng,1,2,* Peng Zheng,1,* Liangliang Yang,1,* Tianyu Liu,1 Yuqiu Xu,1 Dexiang Zhu,1,2 Wenju Chang,1,2 Meiling Ji,1,2 Li Ren,1,2 Ye Wei,1,2 Guodong He,1,2 Jianmin Xu1,2 1Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200030, China; 2Shanghai Engin...
Main Authors: | Mao Y, Feng Q, Zheng P, Yang L, Liu T, Xu Y, Zhu D, Chang W, Ji M, Ren L, Wei Y, He G, Xu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/low-tumor-purity-is-associated-with-poor-prognosis-heavy-mutation-burd-peer-reviewed-article-CMAR |
Similar Items
-
CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy
by: Jiang Chang, et al.
Published: (2022-09-01) -
Comprehensive Characterization of Tumor Purity and Its Clinical Implications in Gastric Cancer
by: Shenghan Lou, et al.
Published: (2022-01-01) -
Tumor purity–associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment
by: Yan Zhao, et al.
Published: (2023-06-01) -
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
by: Yi Xiong, et al.
Published: (2020-01-01) -
Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
by: David Viñal, et al.
Published: (2022-11-01)